Concord Medical Services Holdings (CCM) Cash & Equivalents (2009 - 2025)

Concord Medical Services Holdings (CCM) has 17 years of Cash & Equivalents data on file, last reported at $42.0 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 39.48% year-over-year to $42.0 million; the trailing twelve-month figure through Dec 2025 stood at $42.0 million (up 39.48% YoY), and the FY2025 full-year result was $42.6 million, up 43.75% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $42.0 million, down from $24.8 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $38.2 billion in Q2 2021 and bottomed at $8.1 million in Q4 2023.
• The 5-year median for Cash & Equivalents is $38.4 million (2023), against an average of $9.0 billion.
• The widest annual swing landed in 2021, when Cash & Equivalents jumped 47678.54%; it then tumbled 99.69% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $24.9 million in 2021, then dropped by 9.86% to $22.4 million in 2022, then sank by 63.96% to $8.1 million in 2023, then soared by 272.79% to $30.1 million in 2024, then jumped by 39.48% to $42.0 million in 2025.
• The last three Cash & Equivalents figures came in at $42.0 million (Q4 2025), $24.8 billion (Q2 2025), and $30.1 million (Q4 2024), per Business Quant data.

Peer Comparison